Literature DB >> 33427939

The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.

Billie J Matchett1, Lea T Grinberg2, Panos Theofilas3, Melissa E Murray4.   

Abstract

Alzheimer's disease (AD) is neuropathologically characterized by the intracellular accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β plaques, which affect certain brain regions in a progressive manner. The locus coeruleus (LC), a small nucleus in the pons of the brainstem, is widely recognized as one of the earliest sites of neurofibrillary tangle formation in AD. Patients with AD exhibit significant neuronal loss in the LC, resulting in a marked reduction of its size and function. The LC, which vastly innervates several regions of the brain, is the primary source of the neurotransmitter norepinephrine (NE) in the central nervous system. Considering that NE is a major modulator of behavior, contributing to neuroprotection and suppression of neuroinflammation, degeneration of the LC in AD and the ultimate dysregulation of the LC-NE system has detrimental effects in the brain. In this review, we detail the neuroanatomy and function of the LC, its essential role in neuroprotection, and how this is dysregulated in AD. We discuss AD-related neuropathologic changes in the LC and mechanisms by which LC neurons are selectively vulnerable to insult. Further, we elucidate the neurotoxic effects of LC de-innervation both locally and at projection sites, and how this augments disease pathology, progression and severity. We summarize how preservation of the LC-NE system could be used in the treatment of AD and other neurodegenerative diseases affected by LC degeneration.

Entities:  

Keywords:  Alzheimer’s disease; Locus coeruleus; Norepinephrine; Selective vulnerability; Tau

Year:  2021        PMID: 33427939     DOI: 10.1007/s00401-020-02248-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  162 in total

1.  The pathological process underlying Alzheimer's disease in individuals under thirty.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2010-12-15       Impact factor: 17.088

2.  A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease.

Authors:  R Bowser; J H Kordower; E J Mufson
Journal:  Brain Pathol       Date:  1997-04       Impact factor: 6.508

3.  Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology.

Authors:  P Andrés-Benito; V Fernández-Dueñas; M Carmona; L A Escobar; B Torrejón-Escribano; E Aso; F Ciruela; I Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2017-04-19       Impact factor: 8.090

4.  Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes.

Authors:  W Bondareff; C Q Mountjoy; M Roth; M N Rossor; L L Iversen; G P Reynolds
Journal:  Arch Gen Psychiatry       Date:  1987-05

5.  Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.

Authors:  Csaba Ádori; Laura Glück; Swapnali Barde; Takashi Yoshitake; Gabor G Kovacs; Jan Mulder; Zsófia Maglóczky; László Havas; Kata Bölcskei; Nicholas Mitsios; Mathias Uhlén; János Szolcsányi; Jan Kehr; Annica Rönnbäck; Thue Schwartz; Jens F Rehfeld; Tibor Harkany; Miklós Palkovits; Stefan Schulz; Tomas Hökfelt
Journal:  Acta Neuropathol       Date:  2015-02-13       Impact factor: 17.088

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 7.  The Trk family of neurotrophin receptors.

Authors:  M Barbacid
Journal:  J Neurobiol       Date:  1994-11

8.  Correlations between cortical and subcortical tau pathology.

Authors:  J Attems; A Thomas; K Jellinger
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

9.  Early neurone loss in Alzheimer's disease: cortical or subcortical?

Authors:  Thomas Arendt; Martina K Brückner; Markus Morawski; Carsten Jäger; Hermann-Josef Gertz
Journal:  Acta Neuropathol Commun       Date:  2015-02-10       Impact factor: 7.801

Review 10.  Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.

Authors:  Matthew J Betts; Evgeniya Kirilina; Maria C G Otaduy; Dimo Ivanov; Julio Acosta-Cabronero; Martina F Callaghan; Christian Lambert; Arturo Cardenas-Blanco; Kerrin Pine; Luca Passamonti; Clare Loane; Max C Keuken; Paula Trujillo; Falk Lüsebrink; Hendrik Mattern; Kathy Y Liu; Nikos Priovoulos; Klaus Fliessbach; Martin J Dahl; Anne Maaß; Christopher F Madelung; David Meder; Alexander J Ehrenberg; Oliver Speck; Nikolaus Weiskopf; Raymond Dolan; Ben Inglis; Duygu Tosun; Markus Morawski; Fabio A Zucca; Hartwig R Siebner; Mara Mather; Kamil Uludag; Helmut Heinsen; Benedikt A Poser; Robert Howard; Luigi Zecca; James B Rowe; Lea T Grinberg; Heidi I L Jacobs; Emrah Düzel; Dorothea Hämmerer
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

View more
  17 in total

1.  Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.

Authors:  Michael A Kelberman; Claire R Anderson; Eli Chlan; Jacki M Rorabaugh; Katharine E McCann; David Weinshenker
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

Review 2.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

Review 3.  Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.

Authors:  Boyi Zong; Fengzhi Yu; Xiaoyou Zhang; Wenrui Zhao; Peng Sun; Shichang Li; Lin Li
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

4.  Associations between MRI-assessed locus coeruleus integrity and cortical gray matter microstructure.

Authors:  Jeremy A Elman; Olivia K Puckett; Donald J Hagler; Rahul C Pearce; Christine Fennema-Notestine; Sean N Hatton; Michael J Lyons; Linda K McEvoy; Matthew S Panizzon; Emilie T Reas; Anders M Dale; Carol E Franz; William S Kremen
Journal:  Cereb Cortex       Date:  2022-09-19       Impact factor: 4.861

Review 5.  Sex-Related Predisposition to Post-Traumatic Stress Disorder Development-The Role of Neuropeptides.

Authors:  Małgorzata Lehner; Anna Skórzewska; Aleksandra Wisłowska-Stanek
Journal:  Int J Environ Res Public Health       Date:  2021-12-28       Impact factor: 3.390

Review 6.  Mitochondrial complex I as a therapeutic target for Alzheimer's disease.

Authors:  Eugenia Trushina; Sergey Trushin; Md Fayad Hasan
Journal:  Acta Pharm Sin B       Date:  2021-11-09       Impact factor: 11.413

Review 7.  Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?

Authors:  Mara Mather
Journal:  Semin Cell Dev Biol       Date:  2021-06-04       Impact factor: 7.499

8.  Age-related neuroinflammation and pathology in the locus coeruleus and hippocampus: beta-adrenergic antagonists exacerbate impairment of learning and memory in aged mice.

Authors:  Andrew K Evans; Heui Hye Park; Nay Lui Saw; Kratika Singhal; Gaku Ogawa; Ryan D Leib; Mehrdad Shamloo
Journal:  Neurobiol Aging       Date:  2021-06-20       Impact factor: 5.133

9.  Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer's Disease with Prolonged Sleep Latency.

Authors:  Yoo Hyun Um; Sheng-Min Wang; Dong Woo Kang; Nak-Young Kim; Hyun Kook Lim
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

Review 10.  A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.

Authors:  Karolina Maciejewska; Kamila Czarnecka; Paweł Szymański
Journal:  Pharmacol Rep       Date:  2021-06-13       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.